Announcements Trials
Browse Landscape

Phase

Phase NA 216Phase 2 19Phase 3 10Phase 2/3 6Phase EARLY_PHASE1 4Phase 1 3Phase 4 2Phase 1/2 2

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Breast 1

Conditions

Motor Activity 3Neoplasms 2Weight Loss 1Lung Neoplasms 1Gastrointestinal Neoplasms 1Cardiotoxicity 1Cachexia 1Breast Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Completed × Exercise × Clear all
NCT04131426 2023-08-15

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

University of Rochester

Phase 1 Completed
25 enrolled
GastrointestinalThoracic

Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Motor Activity, Neoplasms, Weight Loss

NCT02006979 2019-10-25

Acute Exercise Cardioprotection From Doxorubicin

University of British Columbia

Phase 1 Completed
27 enrolled 18 charts
Breast

Breast Neoplasms, Motor Activity, Cardiotoxicity

NCT02876627 2016-08-24

Effect Aerobic Training on Women With Breast Cancer After Chemotherapy

University of Isfahan

Phase 1 Completed
30 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡